Effect of Chlorpromazinum on schizophrenia (EChloS)
Phase 2
- Conditions
- Health Condition 1: F20- Schizophrenia
- Registration Number
- CTRI/2024/01/061210
- Lead Sponsor
- Dr S Sudheer Kumar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients of all genders
2. Ages between 18 and 65 years of age
3. Subjects fulfilling ICD 10 diagnostic criteria of Schizophrenia. (F20)
4. Patients under Antipsychotic medication
Exclusion Criteria
1. Patients with comorbid neuro-psychiatric disorders
2. Patients with serious systemic illness.
3. Pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of reduction in positive symptoms of Schizophrenia using Scale for Assessment of Positive Symptoms, after administration of Homoeopathic Chlorpromazinum and Individualized Homoeopathic Medicine in respective groups.Timepoint: Every month from baseline till the conclusion of the study(6th month)
- Secondary Outcome Measures
Name Time Method Assessment of overall improvement in the symptoms of Schizophrenia using Positive and Negative Syndrome Scale, after administration of Homoeopathic Chlorpromazinum and Individualized Homoeopathic Medicine in respective groups.Timepoint: At the baseline and end of the study(6th month);Assessment of reduction in the Side-effects of antipsychotic medications using Glasgow Anti-Psychotics Side-effect Scale after administration of Homoeopathic Chlorpromazinum and Individualized Homoeopathic Medicine in respective groups.Timepoint: Baseline, at 3rd,and conclusion of the study(6th month)